Cancer, Chemotherapy
Conditions
Brief summary
This study evaluates the value of a nursing symptom support en selfmanagement intervention for adult patients with cancer treated with chemotherapy. Using a prospective sequential design with a comparison group who receives standard care and a (later) intervention group who gets the nursing intervention, we will evaluate the effect of this nursing intervention on overall symptom distress (primary outcome) and other measures of symptom burden, self-efficacy, outcome expectations and self-care. By conducting sem-structured interviews with some participants of the intervention group, we will study the patient experience of the intervention.
Interventions
BEHAVIORALNurse support and selfmanagement intervention
Sponsors
Flemish League Against Cancer
Universitaire Ziekenhuizen KU Leuven
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients starting first line treatment with (intravenous) chemotherapy * Ambulatory patients or patients who receive their treatment during short hospital stays * Regardless of type of cancer, treatment or treatment intention (curative or palliative) * Who understand sufficiently Dutch to fill out questionnaires * Who sign informed consent for their participation in the study
Exclusion criteria
* Oral anticancer treatment * Concomitant chemoradiotherapy * Breast cancer patients who receive nurse counseling throughout their therapy * Experimental therapy in the context of a clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall symptom distress | Longitudinal, during first 3 months after start of treatment | Summed symptom distress as self-reported on the Symptom Burden Questionnaire |
| Overall symptom severity | Longitudinal, during first 3 months after start of treatment | Summed symptom severity as self-reported on the Symptom Burden Questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total self-efficacy score | Day 43 of treatment (+/- 1 week) | Outcome will be measured by a self-report questionnaire: shortened version of the Cancer Behavior Inventory |
| Total outcome expectations score | Day 43 of treatment (+/- 1 week) | Outcome will be measured by a self-report questionnaire |
| Total self-care score | Day 85 of treatment (+/- 1 week) | Outcome will be measured by a self-report questionnaire: shortened version of the Leuven- Patient Self-care during chemotherapy scale |
Countries
Belgium
Outcome results
None listed